申请人:——
公开号:US20020128266A1
公开(公告)日:2002-09-12
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
本发明提供了一些化合物,可以提高ABCA-1基因的细胞表达,促进细胞中的胆固醇外流并增加哺乳动物(特别是人类)血浆中的高密度脂蛋白水平。这些化合物可用于治疗冠状动脉疾病。